Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check6 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the locations list.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed. This appears to be a UI/version update with no changes to study data or content.SummaryDifference0.0%

- Check28 days agoChange DetectedRevision log updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.0%

- Check58 days agoChange Detected- Revision: v3.4.2 updated; previous v3.4.1 removed; this is a minor administrative update that does not affect study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedRevision identifier updated from v3.4.0 to v3.4.1. This is a minor metadata update and does not affect study information or functionality.SummaryDifference0.0%

- Check73 days agoChange DetectedUI text updates include a new 'Show glossary' option, a 'Last Update Submitted that Met QC Criteria' label, a 'No FEAR Act Data' note, and a 'Revision: v3.4.0' tag. The prior labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.1%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.